$106 Million is the total value of NQ HCIF GP, Ltd.'s 1 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVNC | REVANCE THERAPEUTICS INC | $105,782,000 | +14.8% | 3,096,650 | 0.0% | 100.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVANCE THERAPEUTICS, INC. | 8 | Q3 2016 | 100.0% |
View NQ HCIF GP, Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2019-10-25 |
| 13F-NT | 2019-07-29 |
| 13F-NT | 2019-05-08 |
| 13F-NT | 2019-02-12 |
| 13F-NT | 2018-11-07 |
| 13F-NT | 2018-08-02 |
| 13F-NT | 2018-04-24 |
| 13F-NT | 2018-02-13 |
| 13F-HR | 2016-10-27 |
| 13F-HR | 2016-07-26 |
View NQ HCIF GP, Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.